A tumor suppressor gene known as p53 is mutated in more than half of all cancers, but how it acts to prevent cancer formation is largely unknown. A study by UT Southwestern Medical Center researchers ...
Found in 70 percent of cancers, the gene is seen as a grand orchestrator, but has been surprisingly difficult to stop. By Carolyn Y. Johnson One of the most elusive and tantalizing targets in cancer ...
CAMBRIDGE, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE)-- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancers, today announced ...
The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found. By Gina Kolata Between 200 and 225 years ago, someone or several someones ...
a message from Kaiser Permanente Sept. 16, 2026, 9:00 a.m. Sept. 17, 2026, 11:13 a.m. Breast cancer is the second leading cause of cancer in U.S. women, with about one in eight developing it in their ...
Despite breakthrough advancements in cancer immunotherapy, significant inter-individual heterogeneity in clinical outcomes persists, bringing the regulatory roles of intrinsic host biological ...
Identification of Predictive Biomarkers for Chemoradiotherapy Response in Rectal Cancer This cross-sectional study identified women with a PV in at least one of 13 breast cancer susceptibility genes ...
Breast cancer is the most common form of cancer among women in Germany: Around 1 in 8 women will develop it during their lifetime. In around 5% to 10% of cases, the condition is caused by a hereditary ...
Scientists have found the first direct evidence of the powerful role our genetic makeup plays in influencing our risk of cancer, with inherited genes interacting with acquired genetic mutations to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results